Mainz Biomed Analyst Ratings
H.C. Wainwright Downgrades Mainz Biomed(MYNZ.US) to Hold Rating
Mainz Biomed Analyst Ratings
Analysts' Top Healthcare Picks: Mainz Biomed B.V. (MYNZ), Century Therapeutics (IPSC)
Mainz Biomed Analyst Ratings
HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3
Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)
Mainz Biomed B.V.: Buy Rating With High CRC Detection Success and AI Integration
Analysts Are Bullish on Top Healthcare Stocks: Mainz Biomed B.V. (MYNZ), Agile Therapeutics (AGRX)
Mainz Biomed Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Mainz Biomed B.V. (MYNZ), Xencor (XNCR) and Biotricity (BTCY)
HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $5
Mainz Biomed Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Mainz Biomed, Maintains $9 Price Target
Mainz Biomed Analyst Ratings
HC Wainwright & Co. Maintains Buy on Mainz Biomed, Raises Price Target to $9
Mainz Biomed Analyst Ratings
H.C. Wainwright Sticks to Their Buy Rating for Mainz Biomed B.V. (MYNZ)
Cantor Fitzgerald Reiterates Overweight on Mainz Biomed, Maintains $9 Price Target
Mainz Biomed Analyst Ratings